Effects of route of administration on the chronic toxicity of reserpine by Rosecrans, John A.
Psychopharmaeologia (Bed.) 10, 452--456 (1967) 
Effects of Route of Administration on the Chronic 
Toxicity of Reserpine* 
J o ~  A. RGS~C~A~S 
Departments of Pharmacology, University of ~r Ann Arbor, Michigan 
and University of Pittsburgh, Pittsburgh, Pennsylvania 
Received April 7, 1965 
W ~ S T ~ A ~ N  (1962) initiMly observed that  single doses of reserpine 
were more potent in lowering brain amine levels when given intramuscu- 
larly than when administered intraperitoneally. More recently BgAG~T 
(1964) has reported comparable differences when cardiac amine levels 
were also studied following various single doses of reserpine. His data 
clearly demonstrates tha t  both the intramuscular and the subcutaneous 
routes were more potent than the intraperitoneal route of administration. 
I t  has further been demonstrated in these laboratories that  the degree 
of toxicity from chronic reserpine t reatment  can also be influenced by  
route of administration. 
Methods 
ttOLTZMA~ (Wisconsin) male albino rats were used in this experiment. 
Reserpine (kindly supplied by  CIBA, Inc., Summit, N.J.)  was adminis- 
tered daily either subcutaneously or intraperitoneally in the following 
vehicle: 5% polyethylene glycol 300, 1% benzyl alcohol and 0.25% 
citric acid. Control rats received 1 ml/kg of this vehicle. Experimental 
groups were selected randomly and animals were housed two/cage for 
convenience in estimating food and water consumption. Food and water 
intake was measured by  difference. Each group received 50 g/day of 
purina rat chow which was placed directly inside the cage. These animals 
were also presented 125 ml/day H~O via standard water bottles. 
Due to the high degree of physical deterioration and difficulty in 
handling chronic reserpinized animals, certain criteria for the duration of 
any single experiment were used. Drug administration to any experimen- 
tal group was terminated when either an LD-50 was attained, or when the 
mean body weight of the group had decreased by  more than 30~ . 
* Part of this research was conducted while on a post-doctoral fellowship at the 
University of Michigan, MH-10,570-02. A preliminary report of these findings was 
presented at the A.A.A.S. meeting in Montreal, 1964. 
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Results 
E/leers o/the ChroMe Administration o/Reserpine on the Growth Rate 
o] Rats when Administered Intraperitoneally 
In  a previous investigation Ros~c~ANS and D~F~o (1965) observed 
tha t  the chronic administration of reserpine to male albino rats did not 
induce severe cumulative effects when administered by  the intraperi- 
toneal route (1 mg/kg for 30 days). Since this observation was not anti- 
cipated, and was in conflict with our previous knowledge of reserpine's 
pharmacology, the particular experiment in question was repeated. The 
results were essentially the same (Table 1). Reserpine produced few 
toxic effects, and did not severely impair the feeding behavior of these 
animals. This was true for at least 42 daily doses of reserpine. 
Table 1. E]]eets o/ reserpine (1 mg/kg, i.p.) on the ]eeding behavior and growth 
rate of male albino rats (42 daily doses) 1 
Init ial  body Final  body Mortali ty Mean daily Mean daily 
weight weight ra te  food intake water intake 
g g Dead/Iq g ml 
Controls 148 • 14 348 • 34 0/12 19.7 ~- 1.4 33.9 -4- 2.9 
Reserpine 158 • 3 217 -4- 9 4/24 15.7 • 1.9 27.8 -4- 2.2 
~ Control 104 63 84 83 
1 All values are means -4- S.E. Also all data are expressed/animal. 
The sedation produced by  this regimen did not appear to be cumula- 
t ive as indicated b y  the gross behavior of these animals, maximal sedation 
developed within 8 hours, whereas minimal sedation was apparent  with 
in 24 hours. Complete recovery to normal behavior was not observed, but  
the degree of sedation at  both the 8th and the 24th hour was similar on 
each day  of reserpine administration. An extremely interesting behav- 
ioral syndrome developed in most  animals following 15 doses of reserpine. 
24 hours following a previous dose reserpinized animals became extremely 
hyperexcitable and hypersensitive to handling and sound stimuli. In  
some cages an increase in fighting behavior was also observed. Unfor- 
tunately this behavior was evident until about  the 30th day of admin- 
istration and was greatly diminished thereafter. 
Two other factors, although not studied extensively, m a y  also be 
important  in maintaining animals for prolonged periods on their daily 
reserpine regimen. Early in these studies it was recognized tha t  animals 
paired with a minimal difference in body weight (not more than 15 g), 
exhibited less toxicity following daily reserpine treatment.  Thus, it is 
recommended tha t  partners demonstrating a great body weight varia- 
tion, while under reserpine t reatment ,  be reassigned new mates in order 
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to minimize the difference. This procedure was carried out routinely on 
each day of the experiment. A second factor which also appears to be 
important, is the weight of the animal at the initiation of an experiment. 
Animals weighing 280--300 g (90--120 days old) were found extremely 
sensitive to chronic reserpinization. 18 of 24 animals died following 14 
doses of reserpine (1 mg/kg, i.p.) with a mean body weight loss of 
t00g .  As observed consistently throughout these studies, animals 
weighing 140--160 g (30--45 days old) tolerated reserpine best. 
E//ects o/the Chronic Administration o/Reserpine on the Growth Rate 
o/Rats when Administered Subcutaneously 
In contrast to the intraperitoneal administration of reserpine, 1 mg/kg 
when administered subcutaneously induced an LD-50 within 8 daily 
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~ig,1.  Effects of  8 daily doses of  reserpine (0.5 mg/kg)  on the growth rate and daily mean food 
and water intake of male albino rats. At the initiation of this experiment, animals weighed 136--156 g 
(iV = 48). The mortality rate of  animals receiving reserpine subcutaneously was 50~ by the eighth 
day. 9 subcutaneous; [ ]  intraperitoneal 
experiment was conducted in which the dose of reserpine was reduced to 
0.5 mg/kg (Fig. 1). At this dosage the subcutaneous route was certainly 
more toxic. A progressive depression of both the gross behavior and 
feeding behavior was also evident. On the other hand, there was no evi- 
dence of any cumulative effect when 0.5 mg/kg reserpine was adminis- 
tered i.p. The sedative effect was mild, and there was no apparent de- 
pression of either the growth rate or feeding behavior during the duration 
of the experiment~ 
To determine the best tolerated s.c. dose of reserpine, a third experi- 
ment was conducted (Table 2). In this last experiment, slightly larger 
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animals were used in order to obtMn a bet ter  spread of  the data.  A posi- 
tive growth  rate  was obtained with only the smMlest dose of  reserpine 
(0.125 mg/kg),  whereas maximal  toxic effects were again observed with 
the 0.5 mg/kg dose. I n  relation to the i.p. route,  0.125 mg/kg appeared 
equivalent  to 0.5 mg/kg. 
Table 2. E/leers o] graded repeated subcutaneous doses o/ reserpine on the /ceding 
behavior and growth rate o/male albino rats 1 
Dose ~ean daily Mean daily i~[ean % change 
n food intake water intake of initial body weight 
mg]kg g ml % 
0.125 6 23.9 • 2.6 37.7 • 5.7 -]- 18.0 4- 11.4 
0.250 6 15.4 :[: 8.3 25.7 :~ 7.3 -- 1.7 • 2.8 
0.500 6 11.9 • 11.7 20.3 ~ 4.7 -- 22.3 • 5.3 
1 All values are means ~: S.E. and all data arc expressed/~nimal (25--27 deter- 
minations). This experiment was conducted for 8 days at which time 50~ of the 
animals receiving 0.500 mg/kg died. Initial weight of these animals was 205 g. 
Discussion 
Classical pharmacology  teaches us that ,  in general, the order of  drug in 
relation to route  of  adminis t rat ion is as follows : in t ravenous > intraperi- 
toneal  > subcutaneous > in t ramuscular  > oral route.  However ,  in con- 
t ras t  to  the ant icipated effect, reserpine produced a much greater  effect 
when administered subcutaneously,  as compared to the intrapcri toneal  
route. W E S ~ M A N  (1962), in an extensive s tudy  of  the influence of  route 
of  adminis t rat ion on the po tency  of  certain drugs, discussed such varia- 
bility. I-Ie concluded that ,  for a drag  to  be more potent  when adminis- 
tered in t ramuscular ly  or subcutaneously,  as compared to the intraperi-  
toneal  route, its ra te  of  metabol ism mus t  be extremely rapid. I n  fact,  for 
such a difference to occur, the rate of  metabolism mus t  be of  the same 
order as, or greater  t han  the rate  of  absorption. Therefore, i t  is suggested 
tha t  the differences between routes in reserpine's toxic effects are the 
result  of  less of  the drug being metabolized following a subcutaneous 
dosage. 
The behavioral  manifestat ions described here are certainly interesting, 
but are at present difficult to explain. In support of these observations, a 
recent study has also demonstrated that reserpine can greatly facilitate 
the hyperexcitability of animals receiving an acute dose of amphetamine 
(Mo~PvnGo and THEOBOLI), 1966). In fact, the described social behavior 
of these animals, for the most part, is characteristic of that behavior 
experienced in this investigation following 15 daily doses of reserpine. 
Nevertheless, it is clear that reserpine can induce a variety of behavioral 
effects, and depending on the route of administration and dosage used, 
one may observe any number of them. 
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Erratum 
The Effects of Posttrial Injections of Pentylenetetrazole, 
Strychnine and Mephenesin on Discrimination Learning 
JARA KI~IVA~V.K and  E ~ L  t tvNT 
Psychopharmaeologia (Berl.) 10, i89--195 (i967) 
The legend to Fig. 1 on page 192 should be read: Decision speeds during the 
learning phase. 
